| Name
|
EGFRvIII Peptide (PEPvIII)
|
| Sequence (Single letter abbreviations)
|
LEEKKGNYVVTDHC
|
| Sequence（Three letter abbreviations）
|
{Leu}{Glu}{Glu}{Lys}{Lys}{Gly}{Asn}{Tyr}{Val}{Val}{Thr}{Asp}{His}{Cys}
|
| Basic description
|
The epidermal growth factor receptor variant III (EGFRvIII) is a consistent tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms. As such it represents a truly tumor-specific target for antitumor immunotherapy.
|
| The molecular weight
|
1634.820
|
| Chemical formula
|
C31H45N6O17P
|
| The purity
|
> 95%
|
| Storage conditions
|
Store at -20°C.
|
| Documents
|
|
| Figures
|
|
| Reference
|
Expert Opin Biol Ther. 2009 Aug;9(8):1087-98.Author:Heimberger AB.
J Immunol Methods. 2008 Nov 30;339(1):74-81. Epub 2008 Sep 4.Author:Schmittling RJ.
|
EGFRvIII Peptide (PEPvIII)
